BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5917090)

  • 1. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine).
    Main AR; Hastings FL
    Science; 1966 Oct; 154(3747):400-2. PubMed ID: 5917090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase inhibition by eserine: rate constants of reaction. Part II.
    Brufani M; Lippa S; Marta M; Oradei A; Pomponi M
    Ital J Biochem; 1985; 34(5):328-40. PubMed ID: 4077467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the in vitro inhibition of acetylcholinesterase by the carbamate inhibitor eserine sulphate in eserine resistant strains of Drosophila melanogaster.
    Burnell AM; Wilkins NP
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(1):215-20. PubMed ID: 2904861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
    Dawson RM
    Neurochem Int; 1994 Feb; 24(2):173-82. PubMed ID: 8161944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new simple method for determining the kinetic constants of inhibited acetylcholinesterase.
    Brufani M; Lippa S; Littarru GP; Oradei A; Pomponi M
    Ital J Biochem; 1984; 33(5):325-32. PubMed ID: 6511307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and dilution effects on the inhibition of acetylcholinesterase by carbamates.
    Winteringham FP; Fowler KS
    Biochem J; 1966 Oct; 101(1):127-34. PubMed ID: 5971773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
    Stojan J; Zorko M
    Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
    Rush RS; Doctor BP; Wolfe AD
    Biochem Pharmacol; 1986 Dec; 35(23):4167-70. PubMed ID: 3098245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of eserine action on the hydrolysis of butyrylthiocholine by butyrylcholinesterase.
    Stojan J; Pavlic MR
    J Enzyme Inhib; 1997 Jan; 11(3):199-208. PubMed ID: 9204388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompetitive inhibition of acetylcholinesterase by eserine.
    Stein HH; Lewis GJ
    Biochem Pharmacol; 1969 Jul; 18(7):1679-84. PubMed ID: 5806108
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient kinetic approach to the study of acetylcholinesterase reversible inhibition by eseroline.
    Golicnik M; Stojan J
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):279-85. PubMed ID: 12683744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds.
    Green AL
    Biochem Pharmacol; 1983 Jun; 32(11):1717-22. PubMed ID: 6870912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
    Marta M; Gatta F; Pomponi M
    Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
    Dawson RM
    Neurochem Int; 1995 Jun; 26(6):643-54. PubMed ID: 7670367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase. II. A study by nuclear magnetic resonance of the acceleration of acetylcholinesterase by atropine and inhibition by eserine.
    Kato G
    Mol Pharmacol; 1972 Sep; 8(5):582-8. PubMed ID: 5083615
    [No Abstract]   [Full Text] [Related]  

  • 16. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.
    Perola E; Cellai L; Lamba D; Filocamo L; Brufani M
    Biochim Biophys Acta; 1997 Nov; 1343(1):41-50. PubMed ID: 9428657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
    Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
    J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
    Debord J; Laubarie C; Dantoine T
    Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.